SCHEMBL6140546

SCHEMBL6140546

CN(CCc1ccc(O)c(O)c1)C(=O)/C=C/c1ccc(O)c(O)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 7/20 0.56
IAPP P10997 4/20 0.51
PTGS1 P23219 1/20 0.51
MMP1 P03956 3/20 0.49
MMP2 P08253 2/20 0.49
MMP9 P14780 2/20 0.49
MET P08581 1/20 0.49
MMP3 P08254 1/20 0.49
MMP12 P39900 1/20 0.49
MMP13 P45452 1/20 0.49
KDM4E B2RXH2 5/20 0.49
MAPT P10636 4/20 0.49
TDP1 Q9NUW8 4/20 0.49
HSD17B10 Q99714 4/20 0.49
TTR P02766 4/20 0.49
POLB P06746 3/20 0.49
GAA P10253 3/20 0.49
HPGD P15428 3/20 0.49
RECQL P46063 2/20 0.49
THRB P10828 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6140549 1.00 APP (0.56) APPIAPPPTGS1MMP1MMP2
SCHEMBL7994636 0.83 RAB9A (0.46) APPKDM4EMAPTTDP1POLB
SCHEMBL7994633 0.83 RAB9A (0.46) APPKDM4EMAPTTDP1POLB
SCHEMBL30364339 0.80 HIF1A (0.50) IAPPPTGS1KDM4EMAPTTDP1
SCHEMBL4878047 0.78 APP (0.62) APPKDM4EMAPTHSD17B10HPGD
SCHEMBL4878055 0.78 APP (0.62) APPKDM4EMAPTHSD17B10HPGD
SCHEMBL26038107 0.78 IAPP (0.66) APPIAPPPTGS1MMP1MMP2
SCHEMBL8848008 0.77 IAPP (0.67) APPIAPPPTGS1MMP1MMP2
SCHEMBL9683152 0.77 IAPP (0.67) APPIAPPPTGS1MMP1MMP2
SCHEMBL4885116 0.76 TRPM8 (0.62) KDM4EMAPTHPGDMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1646480-A Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition MOGAM BIOTECH RES INST (KR) 2005-07-27 CN claimed
US-20040082664-A1 Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition MOGAM BIOTECHNOLOGY RESEARCH INSTITUTE (KR) 2004-04-29 US claimed
WO-2005072723-A1 PHARMACEUTICAL COMPOSITION COMPRISING HYDROXYLPHENYL DERIVATIVES OF ROSMARINIC ACID FOR ANTICANCER MOGAM BIOTECHNOLOGY RESEARCH INSTITUTE (KR) 2005-08-11 WO disclosed
CN-1646480-A Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition MOGAM BIOTECH RES INST (KR) 2005-07-27 CN disclosed
EP-1499585-A1 DERIVATIVES OF HYDROXYPHENYL, A METHOD FOR PREPARING THEREOF AND THEIR PHARMACEUTICAL COMPOSITION Mogam Biotechnology Research Institute (KR) 2005-01-26 EP disclosed
US-20040082664-A1 Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition MOGAM BIOTECHNOLOGY RESEARCH INSTITUTE (KR) 2004-04-29 US disclosed
WO-2003089405-A1 DERIVATIVES OF HYDROXYPHENYL, A METHOD FOR PREPARING THEREOF AND THEIR PHARMACEUTICAL COMPOSITION MOGAM BIOTECHNOLOGY RESEARCH INSTITUTE (KR) 2003-10-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040082664-A1 Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition LCK, SRC, FYN APP 2764/4885IAPP 1162/4885PTGS1 843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.